The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2020 | Early diagnosis: clinical implications
Denis Talbot, BSc, MB, BChir, MA, PhD, FRCP, University of Oxford, Oxford, UK, discusses his research highlights from BTOG 2020, specifically mentioning the release of data from the NELSON trial (ISRCTN63545820) which investigated the effectiveness of CT-based screening in lung cancer patients, and how the medical community can approach an era of earlier diagnosis. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.
